What does this mean for BPI Labs today
and Mayo, L.M., "GLP-1 receptor agonists for the treatment of alcohol use disorder," Journal of Clinical Investigation, May 1, 2025, doi: 10.1172/JCI192414 Hendershot, C.S., et al, "Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial," JAMA Psychiatry, April 1, 2025, doi: 10.1001/jamapsychiatry.2024.4789 Wang, W., et al, "Association of Semaglutide With Tobacco Use Disorder in Patients With Type 2 Diabetes : Target Trial Emulation Using Real-World Data," Annals of Internal Medicine, Aug
(PubMed) Huq MD, Tsai NP, Lin YP, Higgins L, Wei LN
Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure
Preclinical studies have not reported significant adverse effects